Results: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
It was overall a positive result, with revenues beating expectations by 3.5% to hit US$278m. Hims & Hers Health also reported a statutory profit of US$0.05, which was an impressive 310% above what the analysts had forecast. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. See our latest analysis for Hims & Hers Health After the latest results, the 13 analysts covering Hims & Hers Health are now predicting revenues of US$1.22b in 2024. If met, this would reflect a sizeable 27% improvement in revenue compared to the last 12 months. Earnings are expected to improve, with Hims & Hers Health forecast to report a statutory profit of US$0.16 per share. Before this earnings report, the analysts had been forecasting revenue
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $20.00 to $24.00. They now have a "buy" rating on the stock.MarketBeat
- Hims & Hers Health, Inc. (NYSE: HIMS) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $20.00 price target on the stock, up previously from $16.00.MarketBeat
- Hims & Hers Is Changing the Game [Yahoo! Finance]Yahoo! Finance
- Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy [FOX Business Network]FOX Business Network
- Nestlé Launching Frozen Food Brand For Ozempic Users [Forbes]Forbes
HIMS
Earnings
- 5/6/24 - Beat
HIMS
Sec Filings
- 5/22/24 - Form SC
- 5/22/24 - Form 4
- 5/22/24 - Form 4
- HIMS's page on the SEC website